Morepen Laboratories Limited
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and hom… Read more
Market Cap & Net Worth: Morepen Laboratories Limited (MOREPENLAB)
Morepen Laboratories Limited (NSE:MOREPENLAB) has a market capitalization of $254.73 Million (₹22.06 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #16735 globally and #753 in its home market, demonstrating a -0.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Morepen Laboratories Limited's stock price ₹40.26 by its total outstanding shares 547953699 (547.95 Million).
Morepen Laboratories Limited Market Cap History: 2015 to 2026
Morepen Laboratories Limited's market capitalization history from 2015 to 2026. Data shows growth from $238.22 Million to $254.73 Million (8.31% CAGR).
Index Memberships
Morepen Laboratories Limited is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.39 Trillion | 0.01% | #560 of 750 |
Weight: Morepen Laboratories Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Morepen Laboratories Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Morepen Laboratories Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Morepen Laboratories Limited's market cap is 0.01 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.22x
Morepen Laboratories Limited's market cap is 0.22 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $128.76 Million | $4.85 Billion | $128.00 Million | 0.03x | 1.01x |
| 2017 | $236.32 Million | $5.84 Billion | $235.38 Million | 0.04x | 1.00x |
| 2018 | $140.15 Million | $5.98 Billion | $295.91 Million | 0.02x | 0.47x |
| 2019 | $98.39 Million | $7.56 Billion | $288.49 Million | 0.01x | 0.34x |
| 2020 | $194.24 Million | $8.40 Billion | $335.79 Million | 0.02x | 0.58x |
| 2021 | $353.37 Million | $11.75 Billion | $970.86 Million | 0.03x | 0.36x |
| 2022 | $239.48 Million | $15.42 Billion | $1.02 Billion | 0.02x | 0.24x |
| 2023 | $307.18 Million | $14.18 Billion | $386.75 Million | 0.02x | 0.79x |
| 2024 | $494.53 Million | $17.02 Billion | $961.60 Million | 0.03x | 0.51x |
| 2025 | $259.86 Million | $18.30 Billion | $1.18 Billion | 0.01x | 0.22x |
Competitor Companies of MOREPENLAB by Market Capitalization
Companies near Morepen Laboratories Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Morepen Laboratories Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Morepen Laboratories Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Morepen Laboratories Limited's market cap moved from $238.22 Million to $ 254.73 Million, with a yearly change of 8.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹254.73 Million | -1.97% |
| 2025 | ₹259.86 Million | -47.45% |
| 2024 | ₹494.53 Million | +60.99% |
| 2023 | ₹307.18 Million | +28.27% |
| 2022 | ₹239.48 Million | -32.23% |
| 2021 | ₹353.37 Million | +81.92% |
| 2020 | ₹194.24 Million | +97.43% |
| 2019 | ₹98.39 Million | -29.80% |
| 2018 | ₹140.15 Million | -40.70% |
| 2017 | ₹236.32 Million | +83.54% |
| 2016 | ₹128.76 Million | -45.95% |
| 2015 | ₹238.22 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Morepen Laboratories Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $254.73 Million USD |
| MoneyControl | $254.73 Million USD |
| MarketWatch | $254.73 Million USD |
| marketcap.company | $254.73 Million USD |
| Reuters | $254.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.